Message from the Chief
Welcome to the Division of Liver Diseases at Icahn School of Medicine. Mount Sinai is the only medical center in New York with a division focused solely on the treatment of liver diseases. Mount Sinai has more hepatologists on staff than any other hospital or medical center in New York City.
For those of us who have dedicated our lives to the battle against liver disease, this is the most exciting time in our history. Not only is the liver one of the most complicated organs, liver disease is among the fastest-growing of all major illnesses in the United States. Breakthroughs in research, many of them right here at Mount Sinai, are creating new tools to fight this relentless foe.
As one of the few divisions in the nation dedicated exclusively to the study of liver disease, we have built a group that includes many of the world’s top liver clinicians, educators, and researchers. In fact, over the past 60 years, six members of the Mount Sinai faculty have served as president of the American Association for the Study of Liver Diseases.
Our faculty’s expertise not only attracts patients with the most complex conditions, but it also draws the most sought-after hepatologists-in-training to our fellowship program. Our division is home to the first program in the Northeast accredited for advanced hepatology training by the American College of Graduate Medical Education.
Our tradition of excellence in training and patient care creates a multilayered collaboration, which helps us achieve our goal of providing the most compassionate, cutting-edge care — all fueled by the best research and education available anywhere today.
Scott L. Friedman, MD
Chief, Division of Liver Diseases